Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma

[1]  F. Meric-Bernstam,et al.  Targeting the PI3K pathway in cancer: are we making headway? , 2018, Nature Reviews Clinical Oncology.

[2]  R. Verhaak,et al.  Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation , 2016, Nature Genetics.

[3]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[4]  Webster K. Cavenee,et al.  Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance , 2015, Proceedings of the National Academy of Sciences.

[5]  Jill S Barnholtz-Sloan,et al.  Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution , 2015, Genome research.

[6]  A. Arcaro,et al.  Targeting the PI3K/AKT/mTOR signaling pathway in medulloblastoma. , 2015, Current molecular medicine.

[7]  T. Cloughesy,et al.  Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance , 2014, Cancer biology & medicine.

[8]  Franziska Michor,et al.  Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. , 2014, Cancer cell.

[9]  Roland Eils,et al.  Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. , 2014, Cancer cell.

[10]  David T. W. Jones,et al.  Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge , 2014, Nature Reviews Cancer.

[11]  Feng Liu,et al.  mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. , 2013, Cell metabolism.

[12]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[13]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[14]  Scott L. Pomeroy,et al.  Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.

[15]  Serdar Bozdag,et al.  G-Cimp Status Prediction Of Glioblastoma Samples Using mRNA Expression Data , 2012, PloS one.

[16]  S. Armstrong,et al.  mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. , 2012, Cell stem cell.

[17]  Jeffrey A. Magee,et al.  Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. , 2012, Cell stem cell.

[18]  Long-Sheng Chang,et al.  ERK Inhibition Rescues Defects in Fate Specification of Nf1-Deficient Neural Progenitors and Brain Abnormalities , 2012, Cell.

[19]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[20]  Rebecca A. Ihrie,et al.  Lake-Front Property: A Unique Germinal Niche by the Lateral Ventricles of the Adult Brain , 2011, Neuron.

[21]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[22]  Chunxu Qu,et al.  Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. , 2011, Cancer cell.

[23]  F. Zindy,et al.  Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. , 2010, Cancer research.

[24]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[25]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[26]  Y. Wang,et al.  Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. , 2009, Cancer cell.

[27]  Amanda Doucette,et al.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer , 2009, Nature.

[28]  S. Baker,et al.  Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency , 2009, Proceedings of the National Academy of Sciences.

[29]  Webster K. Cavenee,et al.  A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma , 2009, PLoS genetics.

[30]  D. Guertin,et al.  mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. , 2009, Cancer cell.

[31]  Gerald C. Chu,et al.  P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.

[32]  Dawen Zhao,et al.  Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. , 2005, Cancer cell.

[33]  G. Fuller,et al.  Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas , 2004, Laboratory Investigation.